Answers are grounded in this paper and cite their sources.
Interview with Dr. Vinay Rathi on the medical device user-fee program and strategies for supporting device safety and innovation. (10:49)Download User fees are vital to FDA operations. But user-fee legislation has focused on expediting premarketing review rather than understanding device risks and benefits throughout the product life cycle.
No takes yet. Share an insight, caveat, or question.
Rathi et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: